News & Updates
Filter by Specialty:
Erenumab effective for migraine regardless of aura status
28 Jan 2022
byAudrey Abella
In a post hoc analysis, use of the anti-CGRP* receptor monoclonal antibody erenumab led to reduced migraine frequency and AMSM** days in individuals with migraine with and without a history of aura.